Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress!

Affiliations

¹ Division of Infection, Royal London Hospital, Barts NHS Trust, London, United Kingdom. Electronic address: Simon.Tiberi@bartshealth.nhs.uk.
² Emerging Bacterial Pathogens Unit, Division of Immunology and Infectious Diseases, San Raffaele Scientific Institute, San Raffaele Hospital, Milan, Italy.
³ Division of Infection, Royal London Hospital, Barts NHS Trust, London, United Kingdom.
⁴ Maugeri Institute, IRCCS Tradate, Italy.

Comment

Simon Tiberi et al. EBioMedicine. 2018 Mar.

. 2018 Mar:29:11-12.

doi: 10.1016/j.ebiom.2018.02.006. Epub 2018 Feb 8.

¹ Division of Infection, Royal London Hospital, Barts NHS Trust, London, United Kingdom. Electronic address: Simon.Tiberi@bartshealth.nhs.uk.
² Emerging Bacterial Pathogens Unit, Division of Immunology and Infectious Diseases, San Raffaele Scientific Institute, San Raffaele Hospital, Milan, Italy.
³ Division of Infection, Royal London Hospital, Barts NHS Trust, London, United Kingdom.
⁴ Maugeri Institute, IRCCS Tradate, Italy.

No abstract available

Comment on

Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study.
Ismail NA, Omar SV, Joseph L, Govender N, Blows L, Ismail F, Koornhof H, Dreyer AW, Kaniga K, Ndjeka N. Ismail NA, et al. EBioMedicine. 2018 Feb;28:136-142. doi: 10.1016/j.ebiom.2018.01.005. Epub 2018 Jan 9. EBioMedicine. 2018. PMID: 29337135 Free PMC article.

1. Borisov S.E., Dheda K., Enwerem M. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur. Respir. J. 2017;49(5) https://doi.org/10.1183/13993003.00387-2017 pii: 1700387. May 21. - DOI - PubMed
1. Country Updates (Internet) DR-TB STAT. 2017. http://drtb-stat.org/country-updates/ updated 2017 October. Available from:
1. Falzon D., Schünemann H.J., Harausz E., González-Angulo L., Lienhardt C., Jaramillo E. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur. Respir. J. 2017;49(3) Mar 22. - PMC - PubMed
1. Ismail N.A., Omar S.V., Joseph L. Defining bedaquiline susceptibility, resistance, cross-resistance and associated genetic determinants: a retrospective cohort study. EBioMedicine. 2018;28:136–142. - PMC - PubMed
1. Keller P.M., Hömke R., Ritter C., Valsesia G., Bloemberg G.V., Böttger E.C. Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST. Antimicrob. Agents Chemother. 2015;59:4352–4355. - PMC - PubMed